Table 2.
Laboratory indicators of patients with acute compartment syndrome in two groups
| Laboratory indicators | Necrotic muscle group (n = 83) | Non-necrotic muscle (n = 138) | p value |
|---|---|---|---|
| Basophil (BAS, 109/L) | 0.05 (0.01 ~ 0.09) | 0.04 (0.02 ~ 0.07) | 0.593 |
| Basophil, % | 0.40 (0.10 ~ 0.60) | 0.40 (0.11 ~ 0.60) | 0.374 |
| Eosinophil (EOS,109/L) | 0.13 (0.06 ~ 0.18) | 0.12 (0.07 ~ 0.17) | 0.486 |
| Eosinophil, % | 0.90 (0.7 ~ 1.2) | 0.95 (0.7 ~ 0.11) | 0.598 |
| Lymphocyte (LYM, 109/L) | 1.54 (1.12 ~ 2.12) | 1.72 (1.24 ~ 2.13) | 0.206 |
| Lymphocyte, % | 9.9 (7.0 ~ 13.7) | 14.5 (9.0 ~ 20.3) | < 0.0001 |
| Monocyte (MON, 109/L) | 0.93 (0.6 ~ 1.21) | 0.80 (0.59 ~ 1.04) | 0.111 |
| Monocyte, % | 6.2 (4.8 ~ 8.0) | 6.79 (5.3 ~ 8.0) | 0.194 |
| Neutrophil (NEU, 109/L) | 12.4 (7.9 ~ 16.1) | 9.4 (7.0 ~ 12.9) | 0.001 |
| Neutrophil, % | 81.8 (77.0 ~ 85.8) | 77.3 (71.2 ~ 83.6) | < 0.0001 |
| Neutrophil to lymphocyte ratio (NLR) | 8.47 (5.74 ~ 12.09) | 5.65 (3.49 ~ 9.02) | < 0.0001 |
| Platelet (PLT, 109/L) | 216.3 (165.0 ~ 258.0) | 232.9 (190.5 ~ 278.1) | 0.089 |
| Red blood cell (RBC, 1012/L) | 4.33 (3.52 ~ 4.65) | 4.25 (3.80 ~ 4.71) | 0.608 |
| White blood cell (WBC, 109/L) | 14.9 (11.0 ~ 19.5) | 12.0 (9.4 ~ 15.8) | 0.02 |
| Haemoglobin (HGB, g/L) | 132.7 (112.4 ~ 146.4) | 128.1 (116.8 ~ 141.5) | 0.887 |
| Total protein (TP, g/L) | 60.0 (54.3 ~ 63.4) | 58.9 (57.2 ~ 63.4) | 0.904 |
| Albumin (ALB, g/L) | 37.46 (33.2 ~ 39.8) | 37.29 (36.38 ~ 40.53) | 0.213 |
| Globulin (GLOB, g/L) | 22.56 (20.89 ~ 23.90) | 21.74 (20.89 ~ 23.33) | 0.103 |
| A/G | 1.73 (1.40 ~ 1.78) | 1.74 (1.65 ~ 1.76) | 0.171 |
| Creatine kinase, (CK, U/L) | 3387.7 (777.0 ~ 4164.1) | 3337.4 (518.3 ~ 4166.3) | 0.288 |
| Creatine kinase myocardial band (CKMB, U/L) | 104.4 (32.0 ~ 157.0) | 80.3 (22.0 ~ 97.3) | 0.001 |
| CKMB% | 6.39 (2.94 ~ 6.84) | 7.55 (4.01 ~ 8.07) | < 0.0001 |
| Ca2+ (mol/L) | 2.14 (2.09 ~ 2.16) | 2.16 (2.11 ~ 2.23) | 0.001 |
| K+ (mol/L) | 3.94 (3.69 ~ 4.00) | 3.97 (3.91 ~ 3.99) | 0.140 |
| Na+ (mol/L) | 137.2 (136.0 ~ 138.0) | 137.7 (137.4 ~ 138.1) | 0.001 |
| Mg2+ (mol/L) | 0.82 (0.76 ~ 0.84) | 0.84 (0.83 ~ 0.86) | < 0.0001 |
| P3+(mol/L) | 1.16 (0.94 ~ 1.23) | 1.17 (1.12 ~ 1.19) | 0.188 |
| Lactic dehydrogenase (LDH, U/L) | 722.9 (479 ~ 787) | 649.6 (301.2 ~ 743.6) | 0.021 |
| Ureophil (UREA, mol/L) | 5.43 (4.48 ~ 5.79) | 5.11 (4.62 ~ 5.20) | 0.007 |
| Total carbon dioxide (TCO2, mol/L) | 23.45 (22.13 ~ 24.0) | 23.18 (22.73 ~ 24.1) | 0.564 |
| Osmotic pressure (OSM, umol/L) | 269.9 (261.2 ~ 271.2) | 268.9 (267.8 ~ 269.2) | 0.001 |
| Prothrombin time (PT, s) | 12.6 (12.0 ~ 13.5) | 12.4 (11.4 ~ 12.8) | 0.002 |
| International normalized ratio (INR, s) | 1.1 (1.06 ~ 1.18) | 1.09 (1.02 ~ 1.14) | 0.004 |
| Fibrinogen (FIB, g/L) | 2.96 (2.13 ~ 3.15) | 2.86 (2.31 ~ 3.20) | 0.524 |
| Activated partial thromboplastin time (APTT, s) | 30.04 (27.4 ~ 30.44) | 30.75 (28.3 ~ 31.6) | 0.011 |
| Thrombin time (TT, s) | 15.46 (13.8 ~ 16.10) | 15.7 (14.1 ~ 16.19) | 0.426 |
| D-dimer (mg/L) | 4.78 (4.33 ~ 4.97) | 5.91 (5.13 ~ 6.08) | < 0.0001 |
| Antithrombin III (AT III, %) | 95.35 (94.77 ~ 96.03) | 97.00 (74.55 ~ 98.08) | < 0.0001 |